Acadian Asset Management
SLDB icon

Acadian Asset Management’s Solid Biosciences SLDB Stock Holding History

Acadian Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,952
Closed -$27K – 2234
2025
Q4 		$27K Buy
+4,952
New +$26.8K ﹤0.01% 1873
2024
Q3 		– Sell
-67,073
Closed -$379K – 2312
2024
Q2 		$379K Buy
+67,073
New +$601K ﹤0.01% 1290
2023
Q1 		– Sell
-9,507
Closed -$50K – 1951
2022
Q4 		$50K Buy
9,507
+1,547
+19% +$10.1K ﹤0.01% 1582
2022
Q3 		$55K Buy
7,960
+5,809
+270% +$58.6K ﹤0.01% 1486
2022
Q2 		$20K Buy
+2,151
New +$22.4K ﹤0.01% 1615
2022
Q1 		– Sell
-8,227
Closed -$214K – 1783
2021
Q4 		$214K Buy
+8,227
New +$251K ﹤0.01% 1219
2021
Q3 		– Sell
-1,461
Closed -$80K – 1985
2021
Q2 		$80K Buy
+1,461
New +$96.5K ﹤0.01% 1693
2019
Q2 		– Sell
-2,352
Closed -$325K – 2019
2019
Q1 		$325K Buy
+2,352
New +$589K ﹤0.01% 1228

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management's SLDB Position: Q1 2026 in Review

Acadian Asset Management sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 4,952 shares — an estimated $27K sold.

Acadian Asset Management first reported a position in SLDB in Q1 2019 and held it in 8 quarters. The position peaked at $379K in Q2 2024. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Acadian Asset Management reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 4,952 Solid Biosciences shares in Q1 2026, an estimated $27K.
  • Acadian Asset Management first reported a position in Solid Biosciences in Q1 2019 and held it in 8 quarters.
  • Acadian Asset Management's Solid Biosciences position peaked at $379K in Q2 2024.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.